Alzheimer disease: Lack of effect of lecithin treatment for 3 months
The DOI matches its Crossref record.
Abstract
Eleven outpatients with Alzheimer disease of moderate severity completed a double-blind placebo-controlled crossover trial of lecithin. Each patient received 10 gm three times daily of a placebo for 3 months. Plasma choline levels rose threefold and remained at that level throughout the lecithin administration period. A significant difference between mean baseline scores and treatment scores was found on tests of new learning ability, indicating a practice effect in these tests. However, there were no differences between mean placebo and lecithin scores on any of the psychological test measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Subcortical Dementia: Review of an Emerging Concept
Cummings, J. L. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050190080019 · Cited by 541
Treatment of Alzheimer's Disease
Mayeux, R., & Sano, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412207 · Cited by 385
Chan‐Palay, V. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730409 · Cited by 273
Parnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132
Metadata
- Authors
- Etienne, P., Dastoor, D., Gauthier, S., Ludwick, R., & Collier, B.
- Venue
- Neurology
- Published
- 1981-12
- Volume
- 31
- Issue
- 12
- Pages
- 1552-1552
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2007650891
- Cited by
- 70
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer disease: Lack of effect of lecithin treatment for 3 months. https://app.cochat.ai/papers/10.1212/wnl.31.12.1552
- The paper
- Etienne, P., Dastoor, D., Gauthier, S., Ludwick, R., & Collier, B. (1981). Alzheimer disease: Lack of effect of lecithin treatment for 3 months. Neurology. https://doi.org/10.1212/wnl.31.12.1552
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.